Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70034 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Maria Carmen Martorelli und 34 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Benzamides, Pyrimidines, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Momelotinib, a novel JAK1/2 inhibitor with inhibitory activities on activin A receptor type I, has shown breakthrough clinical efficacy in patients with myelofibrosis (MF) and anemia, a disease‐related manifestation of challenging management. In this retrospective real‐life multicenter Italian study, we investigated the safety and efficacy of momelotinib in a cohort of 39 consecutive MF patients, regardless of prior therapy. The median duration of treatment was 7 months, and the overall response rate was 56% in transfusion‐dependent patients and 46% in the transfusion‐independent group. At 24 weeks of treatment, a hemoglobin increase > 1.5 g/dL was observed in 26% of patients, and constitutional symptom improvement was reported in 51% of cases, with a spleen volume reduction > 35% in 28%. Therapy discontinuation occurred in 18% of patients, with only one leukemia progression and three deaths during follow‐up. The safety profile was similar to that reported in clinical trials, with most toxicities of grade I‐II. In conclusion, our real‐life results support the use of momelotinib as an effective and safe therapeutic option for heavily pre‐treated, cytopenic MF patients in real‐world clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
- Hematology and Hematopoietic Stem Cell Transplant Center, University of Naples Federico II, Naples, Italy.
- Hematology Unit, Hospital "Andrea Tortora", Pagani, Italy.
- Department of Medicine, Surgery, and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
- Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, Catanzaro, Italy.
- Hematology and Transplant Center, Ospedale Vito Fazzi, Lecce, Italy.
ORCID-Profile: Novella Pugliese, Danilo De Novellis, Valentina Giudice, Giuseppe Tarantini, Massimo Gentile
Zitieren
APA
Martorelli, M. C., Pugliese, N., Di Perna, M., De Novellis, D., Lombardi, A., De Fazio, L., Loglisci, G., Peluso, I., Molica, M., Copia, C., Ricco, A., Bruzzese, A., Mendicino, F., De Fazio, V., Santeramo, T. M., Bianco, R., Monaco, G., Fontana, R., Guariglia, R., …, & Selleri, C. (2026). Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study. European Journal of Haematology. https://doi.org/10.1111/ejh.70034
Vancouver
Martorelli MC, Pugliese N, Di Perna M, De Novellis D, Lombardi A, De Fazio L, et al. Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study. European Journal of Haematology. 2026. doi:10.1111/ejh.70034
BibTeX
@article{Martorelli2026,
author = {Martorelli, Maria Carmen and Pugliese, Novella and Di Perna, Maria and De Novellis, Danilo and Lombardi, Assunta and De Fazio, Laura and Loglisci, Giuseppina and Peluso, Ilaria and Molica, Matteo and Copia, Carolina and Ricco, Alessandra and Bruzzese, Antonella and Mendicino, Francesco and De Fazio, Vincenza and Santeramo, Teresa Maria and Bianco, Rosario and Monaco, Giuseppe and Fontana, Raffaele and Guariglia, Roberto and Serio, Bianca and Luponio, Serena and Della Corte, Anna Maria and Malandrini, Antonella and Giudice, Valentina and Frigeri, Ferdinando and Tarantini, Giuseppe and Guarini, Attilio and Gentile, Massimo and Musto, Pellegrino and Annunziata, Mario and Di Renzo, Nicola and Rossi, Marco and Califano, Catello and Pane, Fabrizio and Selleri, Carmine},
title = {Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70034}
}
EUVIMED